Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Gregory A. Demopulos,M.D.$186M
Market Cap • 18/04/20241994
(há 30 anos)
2009
(15 years ago)
NASDAQ
Listagem
Seattle
Sede • Washington196
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
OMERSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.